Khyati Shah

6PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated With Clinical Activity.

|Jan 15, 2026
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.

Reinhard Dummer, Shibing Deng, Tao Xie

|Sep 19, 2019
Targeting the evolution of drug resistance in lung cancer.

Khyati Niral Shah, Sourav Bandyopadhyay

|Nov 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

Khyati N Shah, Roma Bhatt, Julia Rotow

|Jun 27, 2018
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.

Hayley J Donnella, James T Webber, Rebecca S Levin

Pageof 1